跳至主要内容
临床试验/NCT00798980
NCT00798980已完成不适用

Scandinavian Mirena Insertion Nulliparous Trial of an Observational Study.

Bayer0 个研究点目标入组 224 人开始时间: 2007年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
Bayer
入组人数
224
主要终点
Evaluation of the insertion procedure of Mirena in nulliparous women

研究概览

简要总结

In this non-interventional study we investigate the nulliparous women individual evaluation of the insertion procedure of LNG-IUD and the follow-up period of 3 months post insertion.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
14 Years 至 —(Child, Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Nulliparous women Mirena insertion planned as contraceptive method

排除标准

  • Ongoing or suspected pregnancy;
  • Ongoing or recidivating genital infection;
  • Cervicitis;
  • Cervical dysplasia;
  • Malignancy in uterus or cervix;
  • Confirmed or suspected hormone sensitive neoplasia including breast cancer
  • Undiagnosed abnormal uterine bleeding;
  • Uterine anomaly including myoma if the cavity of the uterus is restricted;
  • Conditions that cause increased risk of infections;
  • Acute liver disease or liver tumour;
  • Allergy to the active substance or any component of the IUD

研究组 & 干预措施

Arm 1

干预措施: Mirena (BAY86-5028) (Drug)

结局指标

主要结局

Evaluation of the insertion procedure of Mirena in nulliparous women

时间窗: At the insertion time point

次要结局

  • Continuation rate(12-16 weeks post insertion)
  • Pain(At the insertion time point)
  • Bleeding Pattern(12-16 weeks post insertion)
  • Satisfaction(12-16 weeks post insertion)

研究者

发起方
Bayer
申办方类型
Industry

相似试验